X4 Pharmaceuticals (XFOR) Misses Q3 EPS by 4c; Cash and Cash Equivalents of $77.7M
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.76), $0.04 worse than the analyst estimate of ($0.72).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.